A patient with asthma uses a beta-agonist inhaler during an attack; which mechanism explains why bronchodilation occurs more slowly if inflammation chronically elevates histamine levels in the bronchioles?

💡 Explanation

Chronic histamine exposure can lead to desensitization of smooth muscle cells to beta-agonists because the continuous stimulation alters receptor signaling. Therefore, bronchodilation is slower, rather than having a receptor binding issue or an increase in the cAMP cascade from the beta-agonist.

• Following lung injury from asbestos inhalation, which mechanism explains the resolution of inflammation characterized by the return to tissue homeostasis, rather than chronic fibrotic changes?
• If a novel enveloped virus binds ACE2 in human lung epithelial cells, stimulating the pyroptosis pathway in macrophages, which consequence follows?
• A patient with a genetic defect has functional B cells but lacks a thymus. Why does this condition still lead to severely impaired antibody production against T-dependent antigens?
• If a patient reports chronic pain despite lacking peripheral tissue damage, which mechanism best explains the heightened pain perception involving spinal dorsal horn nociceptors?
• Why does excessive consumption of omega-3 fatty acids, such as fish oil supplements, increase bleeding risk during surgery?
• A patient with advanced heart failure exhibits chronically elevated end-diastolic volume. What mechanism most directly diminishes cardiac output under these conditions?